The removal of FDA guidance on clinical trial diversity and related anti–diversity, equity, and inclusion (DEI) actions may hinder progress toward equitable health care, impacting workforce diversity, ...
The investigation was a global endeavor that led to a Post series exposing the Smithsonian's “racial brain collection.” ...